In the adenomyosis group, the multivariable logistic regression analysis results (Table 5, Table 6 and Table 7) show that the administration of GnRH agonist pre-treatment for two months did not improve the clinical birth rate or live birth rate, nor did it change the miscarriage rate. This evidence concerns the gene GNRH1 and adenomyosis.